25.10.2013 Views

Implementation Guidelines - Federal Transit Administration - U.S. ...

Implementation Guidelines - Federal Transit Administration - U.S. ...

Implementation Guidelines - Federal Transit Administration - U.S. ...

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

temperature range (90.0 to 100.0<br />

F). The collector does not take the<br />

employee’s body temperature, but<br />

immediately requires another<br />

collection under direct observation.<br />

The collector observes conduct or<br />

materials that clearly indicates an<br />

attempt to substitute or adulterate the<br />

sample (e.g., substitutes urine in<br />

plain view, blue dye in specimen<br />

presented, etc.).<br />

In the following circumstances the MRO<br />

will direct the employer to have the<br />

employee immediately retested under direct<br />

observation. The employer is required to<br />

comply with the MRO’s request.<br />

The laboratory reported to the MRO<br />

that a specimen was invalid, and the<br />

MRO determined that there was not<br />

an adequate medical explanation for<br />

the result; or<br />

The MRO had to cancel a test when<br />

the primary specimen was verified as<br />

positive, adulterated, or substituted<br />

because the split specimen was<br />

unavailable for testing (i.e., the split<br />

specimen leaked, was lost, or<br />

inadvertently discarded).<br />

In the following circumstance, the<br />

employer must authorize an observed<br />

collection:<br />

The employee has previously been<br />

determined to have used a controlled<br />

substance without medical<br />

authorization and the particular test<br />

is being conducted under the FTA<br />

regulation as a return-to-duty or<br />

follow-up test.<br />

Previously, employers were allowed to<br />

conduct observed collections for tests<br />

following a previous dilute specimen. As of<br />

August 1, 2001, this practice was prohibited.<br />

Observed collections must be performed<br />

with no advance notice to the employee.<br />

The direct observation must be conducted by<br />

a person of the same gender as the employee<br />

being tested. The same gender requirement<br />

also applies to medical professionals who<br />

are observers. The observer can be a<br />

different person from the collector and is not<br />

required to have any special training or<br />

certifications. The observer must follow the<br />

verbal instructions of the collector. The<br />

reason for the direct observation must be<br />

explained to the employee. The observer<br />

must directly watch the urine stream go<br />

from the employee’s body to the collection<br />

container.<br />

Dilute Specimens. A dilute specimen is<br />

a specimen with creatinine and specific<br />

gravity values that are lower than expected<br />

for human urine. If the test is reported as a<br />

dilute positive, the test should be treated as a<br />

verified positive test result. If the test is<br />

reported as a negative dilute, the employer<br />

may, but is not required to direct the<br />

employee to take another test. The retest<br />

must not be conducted under direct<br />

observation. Whatever the employer’s<br />

policy in this regard, all employees must be<br />

treated the same for this purpose and must<br />

be informed in advance of the retest policy.<br />

If the employer requires a retest following a<br />

negative dilute test result, the retest must be<br />

conducted with no advance notice. The<br />

result of the second test becomes the test of<br />

record and there is no opportunity for a third<br />

test, even if the second is also dilute.<br />

Section 3. LABORATORY<br />

TESTING<br />

The scientific techniques used in drug<br />

testing are virtually error-free when properly<br />

applied. The combination of immunoassay<br />

screening with confirmation by gas<br />

chromatography/mass spectrometry<br />

(GC/MS) makes the possibility of error<br />

Chapter 7. Drug Testing Procedures 7-13 August 2002

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!